Ken Ohashi
About
Ken Ohashi is a scholar working on Molecular Biology, Surgery and Oncology.
According to data from OpenAlex, Ken Ohashi has authored 85 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 37 papers in Surgery and 20 papers in Oncology. Recurrent topics in Ken Ohashi's work include Cholesterol and Lipid Metabolism (30 papers), Peroxisome Proliferator-Activated Receptors (18 papers) and Cancer, Lipids, and Metabolism (17 papers). Ken Ohashi is often cited by papers focused on Cholesterol and Lipid Metabolism (30 papers), Peroxisome Proliferator-Activated Receptors (18 papers) and Cancer, Lipids, and Metabolism (17 papers). Ken Ohashi collaborates with scholars based in Japan, United States and United Kingdom. Ken Ohashi's co-authors include Shun Ishibashi, Jun-ichi Osuga, Nobuhiro Yamada, Naoya Yahagi, Yoko Iizuka, Hitoshi Shimano, Yoshiaki Tamura, Takanari Gotoda, Kenji Harada and Hiroaki Okazaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
In The Last Decade
Ken Ohashi
81 papers receiving 6.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ken Ohashi Japan | 37 | 3.2k | 2.5k | 1.3k | 1.1k | 1.1k | 85 | 6.4k | ||
| Yoshiaki Tamura Japan | 33 | 2.8k 0.9× | 2.2k 0.9× | 1.2k 0.9× | 1.1k 1.0× | 947 0.9× | 94 | 6.0k | ||
| Yoko Iizuka Japan | 32 | 3.1k 1.0× | 2.2k 0.9× | 1.1k 0.9× | 1.2k 1.0× | 1.0k 0.9× | 65 | 5.9k | ||
| Takashi Matsuzaka Japan | 39 | 3.3k 1.0× | 2.1k 0.8× | 1.6k 1.3× | 1.0k 0.9× | 1.2k 1.1× | 101 | 6.5k | ||
| Hiroaki Okazaki Japan | 31 | 2.5k 0.8× | 2.1k 0.8× | 994 0.8× | 1.1k 0.9× | 935 0.9× | 75 | 5.0k | ||
| Jun-ichi Osuga Japan | 42 | 3.7k 1.2× | 3.1k 1.2× | 1.6k 1.2× | 1.8k 1.6× | 1.2k 1.1× | 85 | 7.8k | ||
| David L. Silver United States | 40 | 3.7k 1.1× | 2.5k 1.0× | 768 0.6× | 1.2k 1.0× | 709 0.6× | 80 | 6.7k | ||
| Guosheng Liang United States | 35 | 3.8k 1.2× | 3.6k 1.4× | 1.7k 1.3× | 1.3k 1.1× | 1.1k 1.0× | 60 | 8.4k | ||
| Takanari Gotoda Japan | 48 | 3.8k 1.2× | 3.1k 1.2× | 1.4k 1.1× | 1.2k 1.1× | 1.2k 1.1× | 114 | 8.4k | ||
| Russell A. DeBose‐Boyd United States | 35 | 3.8k 1.2× | 3.1k 1.2× | 754 0.6× | 1.1k 1.0× | 1.1k 1.0× | 62 | 6.4k | ||
| Inès Pineda‐Torra United Kingdom | 38 | 4.5k 1.4× | 2.0k 0.8× | 1.4k 1.1× | 606 0.5× | 1.1k 1.0× | 76 | 7.7k |
Countries citing papers authored by Ken Ohashi
Since
Specialization
Citations
This map shows the geographic impact of Ken Ohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Ohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Ohashi more than expected).
Fields of papers citing papers by Ken Ohashi
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ken Ohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Ohashi. The network helps show where Ken Ohashi may publish in the future.
Co-authorship network of co-authors of Ken Ohashi
This figure shows the co-authorship network connecting the top 25 collaborators of Ken Ohashi. A scholar is included among the top collaborators of Ken Ohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Ohashi. Ken Ohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Goto, Atsushi, Ken Ohashi, Mitsuhiko Noda, et al.. (2024). Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer: summary of the results of a questionnaire survey of oncologists and diabetologists—secondary publication. Diabetology International. 15(1). 5–18.
2.
Goto, Atsushi, Ken Ohashi, Mitsuhiko Noda, et al.. (2024). Third Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer: Summary of the results of a questionnaire survey of oncologists and diabetologists—Secondary publication. Cancer Science. 115(2). 672–681.
3.
Maeda, Hiroki, Isao Kobayashi, Miki Takeuchi, et al.. (2023). LSD1 promotes the egress of hematopoietic stem and progenitor cells into the bloodstream during the endothelial-to-hematopoietic transition. Developmental Biology. 501. 92–103.
4.
Goto, Atsushi, Kosuke Inoue, Masataka Taguri, et al.. (2022). Association between diabetes and adjuvant chemotherapy implementation in patients with stage III colorectal cancer. Journal of Diabetes Investigation. 13(10). 1771–1778.
5.
Ogata, Dai, Ken Ohashi, Kohei Yamakawa, et al.. (2022). Type 1 diabetes associated with immune checkpoint inhibitors for malignant melanoma: A case report and review of 8 cases. Medicine. 101(35). e30398–e30398.
6.
Inada, Shuji, Yoko Iizuka, Ken Ohashi, et al.. (2019). Preceding psychological factors and calorie intake in patients with type 2 diabetes: investigation by ecological momentary assessment. BioPsychoSocial Medicine. 13(1). 20–20.
7.
Fujiwara, Yutaka, Shintaro Iwama, Ken Ohashi, et al.. (2018). Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab. Cancer Science. 109(11). 3583–3590.
8.
Udagawa, Hibiki, Shingo Matsumoto, Kenjiro Imai, et al.. (2016). Association of Serum Anti-GAD Antibody and HLA Haplotypes with Type 1 Diabetes Mellitus Triggered by Nivolumab in Patients with Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(5). e41–e43.
9.
Inada, Shuji, Yoko Iizuka, Ken Ohashi, et al.. (2016). Pilot Study for the Development of a Self-Care System for Type 2 Diabetes Patients Using a Personal Digital Assistant (PDA). International Journal of Behavioral Medicine. 23(3). 295–299.
10.
Kasuga, Masato, Kohjiro Ueki, Naoko Tajima, et al.. (2013). Report of the J apan Diabetes Society/J apanese Cancer Association joint committee on diabetes and cancer. Cancer Science. 104(7). 965–976.
11.
Ohta, Keisuke, Motohiro Sekiya, Hiroshi Uozaki, et al.. (2010). Abrogation of neutral cholesterol ester hydrolytic activity causes adrenal enlargement. Biochemical and Biophysical Research Communications. 404(1). 254–260.
12.
Takeuchi, Yoshinori, Naoya Yahagi, Yoshimi Nakagawa, et al.. (2007). In vivo promoter analysis on refeeding response of hepatic sterol regulatory element-binding protein-1c expression. Biochemical and Biophysical Research Communications. 363(2). 329–335.
13.
Yahagi, Naoya, Hitoshi Shimano, Kiyoshi Hasegawa, et al.. (2005). Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. European Journal of Cancer. 41(9). 1316–1322.
14.
Yahagi, Naoya, Hitoshi Shimano, Takashi Matsuzaka, et al.. (2004). p53 Involvement in the Pathogenesis of Fatty Liver Disease. Journal of Biological Chemistry. 279(20). 20571–20575.
15.
Tamura, Yoshiaki, Hideki Adachi, Jun-ichi Osuga, et al.. (2003). FEEL-1 and FEEL-2 Are Endocytic Receptors for Advanced Glycation End Products. Journal of Biological Chemistry. 278(15). 12613–12617.
16.
Yahagi, Naoya, Hitoshi Shimano, Alyssa H. Hasty, et al.. (2002). Absence of Sterol Regulatory Element-binding Protein-1 (SREBP-1) Ameliorates Fatty Livers but Not Obesity or Insulin Resistance in Lep/Lep Mice. Journal of Biological Chemistry. 277(22). 19353–19357.
17.
Perrey, Stéphane, Shun Ishibashi, Naoya Yahagi, et al.. (2001). Thiazolidinedione- and tumor necrosis factor alpha–induced downregulation of peroxisome proliferator–activated receptor gamma mRNA in differentiated 3T3-L1 adipocytes. Metabolism. 50(1). 36–40.
18.
Amemiya-Kudo, Michiyo, Hitoshi Shimano, Tomohiro Yoshikawa, et al.. (2000). Promoter Analysis of the Mouse Sterol Regulatory Element-binding Protein-1c Gene. Journal of Biological Chemistry. 275(40). 31078–31085.
19.
Harada, Kenji, Zhong Chen, Shun Ishibashi, et al.. (1997). Apoptotic cell death in atherosclerotic plaques of hyperlipidemic knockout mice. Atherosclerosis. 135(2). 235–239.
20.
Ishibashi, Shun, Zhong Chen, Jun-ichi Osuga, et al.. (1996). Role of the Low Density Lipoprotein (LDL) Receptor Pathway in the Metabolism of Chylomicron Remnants. Journal of Biological Chemistry. 271(37). 22422–22427.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Yoshiaki Tamura Breakdown of academic impact, for papers by Yoko Iizuka Breakdown of academic impact, for papers by Takashi Matsuzaka Breakdown of academic impact, for papers by Hiroaki Okazaki Breakdown of academic impact, for papers by Jun-ichi Osuga Breakdown of academic impact, for papers by David L. Silver Breakdown of academic impact, for papers by Guosheng Liang Breakdown of academic impact, for papers by Takanari Gotoda Breakdown of academic impact, for papers by Russell A. DeBose‐Boyd Breakdown of academic impact, for papers by Inès Pineda‐Torra